Oryzon Receives 'Decision To Grant' Communications From Canada And Israel For Vafidemstat Patent Applications
July 14 (Reuters) - Oryzon Genomics SA ORY.MC:
RECEIVES 'DECISION TO GRANT' COMMUNICATIONS FROM CANADA AND ISRAEL FOR VAFIDEMSTAT PATENT APPLICATIONS
ONCE FORMALLY GRANTED, CANADIAN AND ISRAELI PATENTS TO REMAIN IN FORCE UNTIL AT LEAST 2038
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.